The CEO of the American pharmaceutical company, Pfizer, Albert Borla, indicated that normal life will return again within a year, but it is likely that it will be necessary to receive an annual dose of Corona vaccines, noting that his company is preparing within days to submit an application for …
Read More »
Today, the U.S. Food and Drug Administration amended the emergency use authorizations for both the Pfizer-BioNTech and Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have …
Read More »
US drugmaker Pfizer raised its forecast for sales of its 2021 vaccine against COVID-19 by 29% to $33.5 billion. The company said it believed people would need a third dose of the vaccine it developed with its German partner BioNTech to maintain a high degree of protection against the virus. …
Read More »
Noor Trends News, Technical Analysis, Educational Tools and Recommendations
